• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE; CLAMP, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE; CLAMP, VASCULAR Back to Search Results
Model Number ICF100
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Information (3190)
Event Date 04/25/2018
Event Type  Injury  
Manufacturer Narrative
The intraclude device is essential to occlude the aorta and provide the necessary cardiac isolation required to perform minimally invasive cardiac surgery procedures.If the intraclude balloon is not totally occlusive during a procedure, the heart would fill and warm, the operative site may be obscured and the procedure may need to convert to an open procedure.The device has been returned for evaluation; however, the analysis is still in progress.A supplemental report will be submitted accordingly once completed.
 
Event Description
Edwards received notification that issues were experienced during the use of an intraclude device model icf100.Indication for surgery was minimal invasive tricuspid valve repair (tvr).During prepping, they only checked that there was no leak at the balloon (they do not check the catheter as per routine).The initial balloon inflation pressure was 300 mmhg.The balloon pressure started falling, the aortic root pressure started rising and the heart started beating.Once the balloon dropped below 250 mmhg, they added extra volume.The 54 ml were added over the duration of the procedure, approximately 2 ml added every 5 minutes.The balloon was deflated once the tvr was completed but before atrium closure because it was not effective so they changed to beating heart surgery.Additional cardioplegia had to be provided.After the tvr, the balloon had to be re-inflated because the valve needed replacing.Again they experienced the same issue while using the intraclude.There was blood in the fluid aspirated from the balloon on deflation and once the balloon was removed, there was visible blood inside the balloon.The patient was hospitalized in stable condition.The balloon was tested after use and the surgical team (very experienced with the intraclude device) found a leak on the catheter where the sizing increases from small diameter at the balloon end to bigger diameter further along the catheter.There was a noticeable seam and fluid identified dripping from this point.The device was cleaned using haz-tabs cleaning solution and was returned for evaluation.
 
Manufacturer Narrative
Evaluation summary: customer complaint of leakage from mid-shaft area was confirmed.As received, the catheter shaft was found kinked near the balloon.The device started leaking at the mid-shaft connection area when inflating the balloon inflation lumen with water.All other through lumens were found to be patent without any leakage or occlusion.No other visual damage or other abnormalities were found.The ifu instructs users to, "visually examine the intraclude device and sterile packaging for evidence of damage (e.G.Rips, tears, etc.).If damaged, do not use".Additional instructions are provided on how to handle the device properly during preparation, insertion, inflation, and removal.Instructions on how to manage leaks and loss of occlusion are also in the ifu.Per the product evaluation and the engineering evaluation, a supplier defect was confirmed.An edwards manufacturing, design, ifu, and labeling defect was not confirmed.The trend was reviewed and was found to be out of control.Corrective action was initiated.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE
Type of Device
CLAMP, VASCULAR
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key7584600
MDR Text Key110573185
Report Number3008500478-2018-00071
Device Sequence Number1
Product Code DXC
Combination Product (y/n)N
PMA/PMN Number
K163693
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 04/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberICF100
Device Catalogue NumberICF100
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/15/2018
Initial Date Manufacturer Received 04/25/2018
Initial Date FDA Received06/08/2018
Supplement Dates Manufacturer Received07/11/2018
07/23/2020
Supplement Dates FDA Received07/19/2018
12/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-